Research graph
References from Maternal per- and polyfluoroalkyl substances exposure and the co-occurrence of gestational diabetes mellitus and preeclampsia/eclampsia: a nested case–control study. Local targets link to admitted publications; unresolved targets remain external evidence.
A clinical update on gestational diabetes mellitus
10.1210/endrev/bnac003 · 2022 · External reference
IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in pregnancy study group's criteria
10.1016/j.diabres.2021.109050 · 2022 · External reference
Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis
10.1111/jdi.12854 · 2019 · External reference
Epidemiology of maternal hypertensive disorders
10.1161/hypertensionaha.124.23765 · 2025 · External reference
Hypertensive disorders in pregnancy: global burden from 1990 to 2019, current research hotspots and emerging trends
10.1016/j.cpcardiol.2023.101982 · 1990 · External reference
Prevalence of hypertensive disorders in pregnancy in China: a systematic review and meta-analysis
10.1016/j.preghy.2021.02.001 · 2021 · External reference
A global view of hypertensive disorders and diabetes mellitus during pregnancy
10.1038/s41574-022-00734-y · 2022 · External reference
Global causes of maternal death: a WHO systematic analysis
10.1016/s2214-109x(14)70227-x · 2014 · External reference
Association between gestational diabetes and pregnancy-induced hypertension
10.1093/aje/kwg273 · 2003 · External reference
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes
10.1056/nejmoa042973 · 2005 · External reference
A multicenter, randomized trial of treatment for mild gestational diabetes
10.1056/nejmoa0902430 · 2009 · External reference
Risk of adverse pregnancy outcomes among pregnant individuals with gestational diabetes by race and ethnicity in the United States, 2014-2020
10.1001/jama.2022.3189 · 2022 · External reference
Impact of gestational diabetes mellitus and hypertensive disorders of pregnancy on adverse pregnancy outcomes: a retrospective cohort study
10.3389/fendo.2026.1805525 · 2026 · External reference
Association of the comorbidity of gestational diabetes mellitus and hypertension disorders of pregnancy with birth outcomes
10.3389/fendo.2024.1468820 · 2024 · External reference
The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity
10.1016/j.ajog.2024.03.009 · 2024 · External reference
Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins
10.1002/ieam.258 · 2011 · External reference
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
10.1039/d0em00291g · 2020 · External reference
Per- and polyfluoroalkyl substances in the environment
10.1126/science.abg9065 · 2022 · External reference
Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: a systematic review
10.1016/j.envint.2022.107149 · 2022 · External reference
Exposure and blood-cerebrospinal fluid barrier permeability of PFASs in neonates
10.1021/acs.estlett.1c00862 · 2021 · External reference
Heightened susceptibility: a review of how pregnancy and chemical exposures influence maternal health
10.1016/j.reprotox.2019.04.004 · 2020 · External reference
Impact of gestational exposure to individual and combined per- and polyfluoroalkyl substances on a placental structure and efficiency: findings from the Ma'anshan birth cohort
10.1021/acs.est.3c09611 · 2024 · External reference
Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes
10.1038/s41591-024-02936-5 · 2024 · External reference
Cross-sectional associations between serum PFASs and inflammatory biomarkers in a population exposed to AFFF-contaminated drinking water
10.1016/j.ijheh.2021.113905 · 2022 · External reference
Antioxidant system alterations and oxidative stress caused by polyfluoroalkyl substances (PFAS) in exposed biota: a review
10.1016/j.scitotenv.2025.179395 · 2025 · External reference
Exposure to elevated per- and polyfluoroalkyl substances in early pregnancy is related to increased risk of gestational diabetes mellitus: a nested case-control study in Shanghai, China
10.1016/j.envint.2020.105952 · 2020 · External reference
Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: a prospective cohort study
10.1016/j.envint.2021.106621 · 2021 · External reference
Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: a nested case-control study
10.1016/j.envpol.2023.121504 · 2023 · External reference
Per- and polyfluoroalkyl substances (PFAS) in drinking water, gestational diabetes mellitus, hypertension and preeclampsia: a nation-wide register-based study on PFAS in drinking water
10.1016/j.envint.2025.109415 · 2025 · External reference
Perfluoroalkyl substances, glucose homeostasis, and gestational diabetes mellitus in Chinese pregnant women: a repeat measurement-based prospective study
10.1016/j.envint.2018.01.027 · 2018 · External reference
Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose
10.1016/j.jes.2018.03.016 · 2018 · External reference
Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy
10.1186/s12940-018-0445-3 · 2019 · External reference
Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study
10.1016/j.envint.2020.105789 · 2020 · External reference
Maternal levels of perfluoroalkyl substances (PFAS) during early pregnancy in relation to preeclampsia subtypes and biomarkers of preeclampsia risk
10.1289/ehp9091 · 2021 · External reference
Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: a nested case-control study in Guangxi, China
10.1016/j.chemosphere.2021.132468 · 2022 · External reference
Potential causal associations between perfluoroalkyl substances exposure and adverse pregnancy outcomes: a bidirectional two-sample mendelian randomization study
10.1016/j.ecoenv.2024.117374 · 2024 · External reference
Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley
10.1289/ehp.1104752 · 2012 · External reference
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study
10.1016/j.envint.2020.105656 · 2020 · External reference
Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian mother and child cohort study
10.1093/aje/kwt432 · 2014 · External reference
In utero exposure to per−/polyfluoroalkyl substances (PFASs): preeclampsia in pregnancy and low birth weight for neonates
10.1016/j.chemosphere.2022.137490 · 2023 · External reference
The maternal drug exposure birth cohort (DEBC) in China
10.1038/s41467-024-49623-0 · 2024 · External reference
The World Health Organization (WHO) versus the International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes
10.1515/hmbci-2017-0077 · 2018 · External reference
Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020)
10.3760/cma.j.cn112141-20200114-00039 · 2020 · External reference
Exploring the relationships between exposure levels of per- and polyfluoroalkyl substances and prostate cancer occurrence in Southwest China. Exposure
10.1007/s12403-025-00703-6 · 2025 · External reference
Estimation of average concentration in the presence of non-detectable values
10.1080/1047322x.1990.10389587 · 1990 · External reference
A Language and Environment for Statistical Computing
2025 · External reference
Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women
10.1038/s41598-019-45483-7 · 2019 · External reference
Exposure to per- and polyfluoroalkyl substances as a risk factor for gestational diabetes mellitus through interference with glucose homeostasis
10.1016/j.scitotenv.2022.156561 · 2022 · External reference
Gestational diabetes and offspring birth size at elevated environmental pollutant exposures
10.1016/j.envint.2017.07.016 · 2017 · External reference
Per- and Polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: a case-control study in southern Sweden
10.3390/toxics8020043 · 2020 · External reference
A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes
10.1016/j.fertnstert.2014.10.001 · 2015 · External reference
Associations of per- and Polyfluoroalkyl substances (PFAS) with glucose tolerance during pregnancy in project viva
10.1210/clinem/dgaa328 · 2020 · External reference
